Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 28 studies | 26% ± 7% | |
endothelial cell of lymphatic vessel | 20 studies | 34% ± 12% | |
fibroblast | 15 studies | 22% ± 5% | |
capillary endothelial cell | 13 studies | 21% ± 4% | |
vein endothelial cell | 11 studies | 24% ± 6% | |
ciliated cell | 7 studies | 23% ± 6% | |
endothelial cell of artery | 6 studies | 20% ± 5% | |
epithelial cell | 6 studies | 33% ± 10% | |
basal cell | 6 studies | 28% ± 12% | |
classical monocyte | 5 studies | 27% ± 13% | |
myofibroblast cell | 5 studies | 21% ± 6% | |
smooth muscle cell | 5 studies | 20% ± 2% | |
connective tissue cell | 5 studies | 17% ± 1% | |
endothelial cell of vascular tree | 4 studies | 23% ± 2% | |
type I pneumocyte | 4 studies | 21% ± 5% | |
glomerular endothelial cell | 3 studies | 22% ± 1% | |
pericyte | 3 studies | 17% ± 2% | |
adventitial cell | 3 studies | 20% ± 7% | |
respiratory goblet cell | 3 studies | 21% ± 6% | |
secretory cell | 3 studies | 24% ± 6% | |
endothelial cell of sinusoid | 3 studies | 25% ± 13% | |
macrophage | 3 studies | 18% ± 2% | |
transit amplifying cell | 3 studies | 35% ± 20% | |
goblet cell | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10537.15 | 1445 / 1445 | 100% | 23.90 | 183 / 183 |
skin | 100% | 6559.92 | 1809 / 1809 | 100% | 37.31 | 472 / 472 |
thymus | 100% | 8308.91 | 653 / 653 | 100% | 33.54 | 605 / 605 |
intestine | 100% | 9507.07 | 966 / 966 | 100% | 25.48 | 526 / 527 |
uterus | 100% | 11028.98 | 170 / 170 | 100% | 29.30 | 458 / 459 |
ovary | 100% | 8542.07 | 180 / 180 | 100% | 19.74 | 429 / 430 |
kidney | 100% | 5649.92 | 89 / 89 | 100% | 32.68 | 898 / 901 |
stomach | 100% | 6898.59 | 359 / 359 | 100% | 24.71 | 285 / 286 |
breast | 100% | 8587.16 | 459 / 459 | 100% | 20.83 | 1114 / 1118 |
prostate | 100% | 8213.88 | 245 / 245 | 100% | 23.59 | 500 / 502 |
bladder | 100% | 10511.10 | 21 / 21 | 99% | 28.68 | 501 / 504 |
lung | 100% | 8547.50 | 577 / 578 | 99% | 22.65 | 1145 / 1155 |
pancreas | 97% | 2911.16 | 317 / 328 | 100% | 29.77 | 178 / 178 |
adrenal gland | 100% | 6871.72 | 258 / 258 | 94% | 16.28 | 217 / 230 |
liver | 96% | 2127.31 | 217 / 226 | 94% | 16.84 | 380 / 406 |
brain | 71% | 1296.19 | 1869 / 2642 | 98% | 14.65 | 694 / 705 |
adipose | 100% | 9002.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.67 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.11 | 29 / 29 |
spleen | 100% | 9489.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.10 | 1 / 1 |
heart | 100% | 6960.60 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7644.73 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 95% | 2157.78 | 759 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 4080.22 | 846 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900026 | Biological process | positive regulation of substrate adhesion-dependent cell spreading |
GO_0007605 | Biological process | sensory perception of sound |
GO_0060088 | Biological process | auditory receptor cell stereocilium organization |
GO_0051301 | Biological process | cell division |
GO_0051016 | Biological process | barbed-end actin filament capping |
GO_0030047 | Biological process | actin modification |
GO_0005813 | Cellular component | centrosome |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0030496 | Cellular component | midbody |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005925 | Cellular component | focal adhesion |
GO_0120044 | Cellular component | stereocilium base |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0045159 | Molecular function | myosin II binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | TRIOBP |
Protein name | TRIO and F-actin binding protein TRIO and F-actin-binding protein (Protein Tara) (TRF1-associated protein of 68 kDa) (Trio-associated repeat on actin) TRIO and F-actin-binding protein |
Synonyms | TARA HRIHFB2122 KIAA1662 |
Description | FUNCTION: [Isoform 1]: Regulates actin cytoskeletal organization, cell spreading and cell contraction by directly binding and stabilizing filamentous F-actin and prevents its depolymerization . May also serve as a linker protein to recruit proteins required for F-actin formation and turnover . Essential for correct mitotic progression . .; FUNCTION: [Isoform 5]: Plays a pivotal role in the formation of stereocilia rootlets. .; FUNCTION: [Isoform 4]: Plays a pivotal role in the formation of stereocilia rootlets. . |
Accessions | F6WMF4 ENST00000418339.5 F6WYE2 ENST00000428075.5 H7BXW4 F6TR96 ENST00000344404.10 ENST00000407319.7 [Q9H2D6-6] ENST00000452519.5 ENST00000417857.1 H0Y5J9 ENST00000403663.6 [Q9H2D6-7] H0Y5T8 Q9H2D6 ENST00000413051.2 ENST00000644935.1 [Q9H2D6-1] A0A1S5UZ31 |